Fisher Daninainsider trades
In SEC Form 4 filings, Fisher Danina is listed as Director of Hepion Pharmaceuticals, Inc. (HEPA). In the last 90 days, Fisher Danina bought $10K of Hepion Pharmaceuticals, Inc. (HEPA) on the open market and sold none. The purchase was $10K of Hepion Pharmaceuticals, Inc. (HEPA) on Sep 29.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| HEPAHepion Pharmaceuticals, Inc. | Director | 3 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| HEPAHepion Pharmaceuticals, Inc. | Sep 29 | Oct 2 | P | 200,000 | $0.05 | Purchase +$10,000 | 200,000 | No | Form 4 |
| HEPAHepion Pharmaceuticals, Inc. | Sep 29 | Oct 2 | P · derivative | 200,000 | $0.06 | Purchase +$12,000 | 200,000 | No | Form 4 |
| HEPAHepion Pharmaceuticals, Inc. | Aug 19 | Aug 21 | A · derivative | 299,000 | $0.08 | $23,920 | 299,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.